The management of benign prostatic hyperplasia: Treatment Approaches to BPH
Buy non prescription drugs: Asacol, Diamox
Because benign prostatic hyperplasia (BPH) rarely causes serious complications, men usually have a choice between seeking treatment for BPH or opting for watchful waiting. The primary goals of treatment for benign prostatic hyperplasia are to improve urinary flow and to reduce symptoms. Many treatment options are available, including drug therapies, minimally invasive procedures, and major surgery. Watchful waiting involves lifestyle changes and an annual examination. Even in the case of watchful waiting, an initial examination is critical to rule out any other prostate disorders.
The decision between watchful waiting and treatment usually depends on a number of factors, such as urine flow rates, prostate size, PSA prostate specific antigen) levels, and IPSS (International Prostate Symptoms Score). The ultimate choice is often guided primarily by a man’s perception of his own symptoms.
Men with mild or no symptoms (IPSS scores of 7 or below) usually choose watchful waiting even if their prostates are enlarged. It should be noted, however, that urinary tract obstructions may be present in men with enlarged prostates even if they have no symptoms. Men with severe symptoms (IPSS scores over 20) usually choose treatment. The choice is most difficult for men with moderate symptoms (IPSS scores between 8 and 19) and how well they can tolerate symptoms. One study of men with moderate symptoms compared two groups: one selected for watchful waiting and the other for transurethral resection of the prostate (TURP). After five years, only 10% of those who had undergone TURP experienced worsened condition or a return of symptoms compared to 21% of those who had been selected for watchful waiting. This study did not include men on pharmacotherapy for benign prostatic hyperplasia.
Benign prostatic hyperplasia eventually progresses to the point of needing treatment in about 15% of men with mild symptoms who employ watchful waiting and in up to 40% of those with moderate symptoms. However, in a small percentage of patients, symptoms improve. Men with BPH who develop symptoms at a younger age (around age 50) are more likely to need treatment within their lifetimes than older men. At present, there is limited capability to determine high-risk patients.
Buy non prescription drugs: Asacol, Diamox
This post has been viewed 46 times.
Related posts:
- Management of benign prostatic hyperplasia (BPH) Buy non prescription drugs: Asacol, Diamox The National Prescribing Centre (NPC) [UK] Summary Symptoms of benign prostatic hyperplasia (BPH) are common in older men. They result from hyperplasia of glandular tissue and increased smooth muscle tone. Many men accept these symptoms as a...
- Benign prostatic hyperplasia. Part 7: Treatment Buy non prescription drugs: Asacol, Diamox Alternative surgical treatment Many alternative procedures have been tried, including transurethral incision of prostate (TUIP), which is less likely to produce retrograde ejaculation and may have lower morbidity rates but higher re-operative rates (up to 20% at...
- Moderate symptoms of benign prostatic hyperplasia. Part 1 Buy non prescription drugs: Asacol, Diamox The urinary symptoms of benign prostatic hyperplasia (BPH) can range from very mild to severe enough to require prompt surgical treatment. Men with moderate symptoms of BPH do not face immediate health risks, but are typically bothered...
- The management of benign prostatic hyperplasia: Diagnostic Indicators Buy non prescription drugs: Asacol, Diamox An indexing tool called the International Prostate Symptoms Score (IPSS) II can help evaluate key lower urinary tract symptoms. The patient’s score on this test gives a highly accurate assessment of the effect of lower urinary tract...
- Management of Benign Prostatic Hyperplasia (BPH): Treatment Buy non prescription drugs: Asacol, Diamox Treatment for benign prostatic hyperplasia (BPH) must be patient specific and includes watchful waiting and monitoring, pharmacotherapy, minimally invasive therapy and surgery. Certain patients may benefit more from surgery than pharmacotherapy based upon results of the clinician’s...
Posted in: Benign Prostatic Hyperplasia